Treating non-Hodgkin’s lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.
Radiation may lower potential for side effects of CAR T therapy in non-hodgkin’s lymphoma
